Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 4 1

Status

Completed 5Recruiting 4Unknown 2Terminated 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Endocrine 2NET 1

Conditions

Neuroendocrine Tumors 1Gastric Cancer After D2 Lymph Node Dissection 1Gallbladder Neoplasms 1Carcinoma, Hepatocellular 1Carcinoid Tumor 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Somatostatin × Clear all
NCT02795858 2025-02-19

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

Dana-Farber Cancer Institute

Phase 2 Completed
43 enrolled 11 charts
Endocrine

Carcinoid Tumor

NCT04129255 2020-09-10

CSMS99

National Cancer Institute, Naples

Phase 2 Completed
34 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT01053390 2013-12-20

New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

Shanghai Jiao Tong University School of Medicine

Phase 3 Completed
216 enrolled
Gastrointestinal

Gallbladder Neoplasms

NCT01914692 2013-08-02

Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection

First Affiliated Hospital, Sun Yat-Sen University

Phase 4 Completed
2 enrolled
Gastrointestinal

Gastric Cancer After D2 Lymph Node Dissection

NCT00386984 2006-10-12

Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma

University Hospital Freiburg

Phase 3 Completed
108 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡